Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1991
Pharmacologically based dosing of etoposide: a means of safely increasing dose intensityM J Ratain, R Mick, R L Schilsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studiesH Minami, T E Lad, M K Nicholas, et al.
American Journal of Clinical Pathology|February 1, 1986
Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemiaR G Bardawil, C Groves, M J Ratain, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Dose-escalation trial of cladribine using five daily intravenous infusions in patients with advanced hematologic malignanciesR A Larson, R Mick, R T Spielberger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I studyE E Vokes, S M O'Brien, N J Vogelzang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Perceptions of cancer patients and their physicians involved in phase I trialsC Daugherty, M J Ratain, E Grochowski, et al.
Cancer Research|January 1, 1994
Phase I and pharmacokinetic study of a new antineoplastic agent: pyrazine diazohydroxide (NSC 361456)N J Vogelzang, R Mick, L Janisch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrheaF Innocenti, W M Stadler, L Iyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Phase I study of suramin given by intermittent infusion without adaptive control in patients with advanced cancerK Kobayashi, E E Vokes, N J Vogelzang, et al.
Pageof 19